REFRACTORY LYMPHOBLASTIC LYMPHOMA
Clinical trials for REFRACTORY LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for REFRACTORY LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to beat back tough blood cancers
Disease control Recruiting nowThis study is for people whose acute lymphoblastic leukemia, lymphoblastic lymphoma, or related blood cancers have returned or stopped responding to treatment. Researchers are testing a combination of six chemotherapy drugs to see if it can shrink tumors and control the disease. …
Matched conditions: REFRACTORY LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 08:21 UTC
-
Triple-Target CAR t cells take on tough blood cancers
Disease control Recruiting nowThis early-stage trial tests a new type of immunotherapy called TriCAR19.20.22 T cells for people with certain blood cancers (non-Hodgkin lymphoma, acute lymphoblastic leukemia, and chronic lymphocytic leukemia) that have returned or not responded to prior treatments. The therapy…
Matched conditions: REFRACTORY LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:51 UTC